Core Viewpoint - The AI Fund Zhaoshang China Opportunity Stock (001749) reported a profit of 4.3172 million yuan for Q2 2025, with a weighted average profit per fund share of 0.0328 yuan, indicating a net value growth rate of 2.48% during the period [3]. Fund Performance - As of the end of Q2 2025, the fund's scale was 183 million yuan [15]. - The fund's unit net value was 1.452 yuan as of July 17 [3]. - The fund manager, Li Huajian, oversees two funds, both of which have shown positive returns over the past year [3]. - The fund's one-year compounded net value growth rate reached 18.53%, ranking it 87 out of 166 comparable funds [3]. - Over the past three months, the fund's compounded net value growth rate was 9.75%, ranking 86 out of 167 comparable funds [3]. - The fund's six-month compounded net value growth rate was 5.60%, ranking 122 out of 167 comparable funds [3]. - The fund's three-year compounded net value growth rate was -29.86%, ranking 141 out of 159 comparable funds [3]. Risk Metrics - The fund's three-year Sharpe ratio was -0.2043, ranking 130 out of 159 comparable funds [8]. - The maximum drawdown over the past three years was 50.43%, ranking 14 out of 158 comparable funds [10]. - The largest single-quarter drawdown occurred in Q1 2021, at 23.46% [10]. Investment Strategy - The fund management remains optimistic about the structural market trends in A-shares, citing improvements in domestic economic growth and structural transformation [3]. - The fund is particularly focused on investment opportunities in sectors such as AI, pharmaceuticals, military industry, and media [3]. Portfolio Composition - As of the end of Q2 2025, the fund's top ten holdings included Changying Tong, Zhongke Feice, Jingyi Equipment, Boqian New Materials, Youfang Technology, Hudian Co., Changchuan Technology, Xinyi Sheng, Jinqiao Information, and Chip Origin Technology [18]. - The average stock position over the past three years was 89.19%, compared to the industry average of 87.97% [13]. - The fund reached a maximum stock position of 93.14% at the end of H1 2025, with a minimum of 79.84% at the end of H1 2024 [13].

Meeting Information - The first extraordinary general meeting of shareholders for 2025 will be held on August 1, 2025, at 14:30 [1] - The meeting will take place at the company's conference room located at 501, B3 Building, Bio-Nano Park, 218 Xinghu Street, Suzhou Industrial Park [1] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's voting system [1] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's online voting system on the day of the meeting from 9:15 to 15:00 [1][2] - Specific voting times for the trading system are from 9:15-9:25, 9:30-11:30, and 13:00-15:00 [1] - Shareholders must complete identity verification to vote on the internet platform [2] Agenda Items - The meeting will review a proposal to cancel the supervisory board and amend the company's articles of association [2] - The proposal has already been approved by the company's board and supervisory board in previous meetings [2] Attendance Requirements - Shareholders registered by the close of trading on July 25, 2025, are eligible to attend the meeting [4] - Shareholders can appoint a proxy to attend and vote on their behalf [4] - Specific documentation is required for both corporate and individual shareholders to register for the meeting [5] Additional Information - Shareholders wishing to attend must confirm their attendance by July 31, 2025, via email [5] - Contact details for inquiries include a phone number and email address for the company [6]

Group 1 - The company has decided to abolish the supervisory board and transfer its responsibilities to the audit committee of the board of directors [1][2] - The proposal to cancel the supervisory board and amend the articles of association will be submitted for approval at the company's first extraordinary general meeting of shareholders in 2025 [1][2] - The internal control systems related to the supervisory board will be abolished, and corresponding amendments will be made to the articles of association and the rules of procedure for the general meeting of shareholders [1][2] Group 2 - The amendments to the articles of association aim to improve the corporate governance structure and enhance compliance with relevant laws and regulations [2] - Specific amendments include changes to the legal representative's role, the company's registered capital, and the rights and obligations of shareholders [2][4] - The new articles of association will ensure that the company operates in accordance with the latest legal requirements and best practices [2][4]

Core Viewpoint - The company plans to increase its estimated daily related party transaction limit for 2025, which is deemed necessary for its normal business operations and will not affect its independence or harm the interests of shareholders [1][2][3] Daily Related Party Transactions - The board of directors and independent directors have approved the increase in the estimated daily related party transaction limit, with a total expected amount of 9.5516 million yuan (excluding tax) for transactions with ISDI LIMITED [2][3] - The increase is based on normal business operations and market pricing, ensuring fair pricing and no adverse impact on the company's financial condition or operational results [2][3] Transaction Details - The estimated amount for the daily related party transactions is 9.5516 million yuan, which represents 3.91% of the total expected transactions for the year [4] - Previous related party transactions with ISDI included sales and purchases, with actual amounts significantly lower than the previously estimated amounts [5] Related Party Information - ISDI LIMITED is a private limited company established in 2010, with a registered capital of 1,172.574 GBP and a focus on the development and sale of CMOS-X ray detectors and CMOS image sensors [6] - The company has a stable business relationship with ISDI, which is necessary for its operational needs [7] Purpose and Impact of the Transactions - The increase in the estimated daily related party transaction limit is essential for the company's business development and production operations, aligning with the interests of the company and all shareholders [6][7] - Transactions with related parties are conducted under normal market conditions, ensuring compliance with commercial practices and maintaining the company's independence [7]

Core Points - The internal audit system of Jiangsu Kangzhong Digital Medical Technology Co., Ltd. aims to standardize internal audit work, enhance quality, protect investor rights, and promote sustainable development [2][4] Group 1: General Principles - The internal audit is defined as an evaluation activity conducted by internal personnel to assess the effectiveness of internal controls, risk management, and the authenticity and completeness of financial information [4] - The internal audit department operates under the leadership of the board's audit committee and is responsible for reporting its work to the committee [3][4] Group 2: Responsibilities and Authority - The internal audit department has the authority to request relevant documents, review financial statements, inspect computer systems, and investigate any obstruction to the audit process [5][6] - Internal auditors are required to adhere to professional ethics, remain objective, and are protected by law from retaliation [5][7] Group 3: Audit Duties and Content - The internal audit department is responsible for evaluating the integrity and effectiveness of internal controls, auditing financial data for legality and compliance, and assisting in establishing anti-fraud mechanisms [6][8] - Reports on internal audit findings must be submitted to the audit committee at least quarterly, and a comprehensive report is required at the end of each fiscal period [6][8] Group 4: Audit Procedures - The internal audit process includes planning, notifying the audited unit, and conducting the audit using various methods to gather sufficient evidence [10] - Audit reports are drafted and sent to the audited unit for feedback, and follow-up audits are conducted to ensure compliance with audit recommendations [10][9] Group 5: Audit Requirements - Internal auditors must possess relevant professional knowledge and experience, and the company must ensure their ability to perform their duties without interference [7][8] - Any violations of laws or internal regulations must be reported promptly, and auditors are responsible for the accuracy of their reports [8][9] Group 6: Rewards and Penalties - The company will hold accountable any unit or individual responsible for significant violations of financial laws, and internal auditors who face retaliation can report to management [10][10] - Internal auditors demonstrating diligence and integrity will be rewarded, while those abusing their power will face disciplinary actions [10][10]

Core Points - The document outlines the external guarantee management measures of Jiangsu Kangzhong Digital Medical Technology Co., Ltd to protect investor interests and regulate the company's guarantee behavior [1] - The company aims to control asset operation risks and promote stable development in accordance with relevant laws and regulations [1] Chapter 1: General Principles - The external guarantee refers to the guarantees provided by the company for others, including guarantees for its subsidiaries [1] - All external guarantees must be managed uniformly by the company and require approval from the board of directors or shareholders [1] Chapter 2: Guarantee and Management Section 1: Guarantee Objects - The company can provide guarantees for entities with independent legal status that meet specific conditions, including those with significant business relationships with the company [2] - All guarantee applicants must have strong debt repayment capabilities [2] Section 2: Guarantee Management Functions and Approval Procedures - The finance department is responsible for managing guarantees, and must assess the credit status of the guarantee applicants before approval [2][3] - The approval process requires a thorough analysis of the applicant's financial status and relevant documentation [2] Section 3: Guarantee Review and Decision Authority - The board of directors must carefully review the financial status and creditworthiness of guarantee applicants [3][4] - Certain guarantees require submission to the shareholders' meeting for approval if they exceed specified thresholds related to the company's net assets [4] Section 4: Signing Guarantee Contracts - Guarantee contracts must comply with legal norms and be reviewed by legal counsel if necessary [5][6] - The company must ensure that all obligations in the guarantee contracts are clearly defined [6] Chapter 3: Guarantee Risk Management Section 1: Management Before Creditors Assert Claims - The board of directors and finance department are responsible for managing guarantee behaviors and monitoring the repayment obligations of the guaranteed parties [7] - Any significant changes in the financial status of the guaranteed parties must be reported to the finance department [7] Section 2: Management When Creditors Assert Claims - The company must initiate recovery procedures if the guaranteed party fails to fulfill its obligations [8] - The company should not assume guarantee responsibilities without board approval if there are ongoing disputes [8] Chapter 4: Responsibilities of Responsible Persons - Company directors and management personnel are liable for damages caused by unauthorized guarantee contracts [9] - Departments that violate regulations or fail to perform their duties may face penalties and compensation responsibilities [9] Chapter 5: Supplementary Provisions - The terms used in the document align with those in the company's articles of association [9] - The document becomes effective upon approval by the board of directors [9]

Core Points - The document outlines the major operational and investment decision-making management system of Jiangsu Kangzhong Digital Medical Technology Co., Ltd, aiming to ensure scientific, standardized, and transparent decision-making processes while safeguarding the interests of the company and its shareholders [1][2]. Decision Principles - The principles for major operational and investment decisions include legality, prudence, safety, and effectiveness, focusing on controlling investment risks and emphasizing investment returns [1]. Decision Scope - Major operational matters include significant financing, signing major purchase or sales contracts, and the acquisition or disposal of fixed assets [2]. - Investment matters encompass the purchase or sale of assets (excluding daily operational transactions) and external investments (excluding low-risk bank financial products) [2]. Approval Authority - The General Manager's office can decide on matters where the audited total assets do not exceed 10% of the latest audited total assets, or where the audited annual revenue does not exceed 10% or 10 million yuan [4]. - Matters requiring Board approval include those exceeding 10% but less than 50% of the latest audited total assets, or where the audited annual revenue exceeds 10% and is above 1 million yuan but below 5 million yuan [4][5]. Decision Procedures - The decision-making process for major contracts requires the General Manager to report to the Board for contracts exceeding their authority but not reaching shareholder approval thresholds [6]. - For fixed asset purchases, the approval process involves the General Manager, Board, and potentially the shareholders, depending on the amount [6]. Feasibility Studies - Before external investments, project initiators must prepare a feasibility study report, which requires approval from the General Manager and must comply with legal and regulatory requirements [8]. Execution and Supervision - The execution of major operational and investment decisions is the responsibility of the business departments and branches, which must create specific implementation plans [8]. - Financial managers must ensure proper funding allocation for the successful implementation of investment projects [8]. Legal Responsibilities - Directors involved in decision-making that leads to significant losses due to procedural violations may be held liable for damages [9]. - The General Manager's office can impose penalties on members for actions that contradict Board decisions resulting in economic losses [9][10].

Core Viewpoint - The document outlines the selection and appointment procedures for accounting firms by Jiangsu Kangzhong Digital Medical Technology Co., Ltd, emphasizing the importance of maintaining shareholder interests and ensuring high-quality audit work and financial information. Group 1: General Principles - The purpose of the selection system is to standardize the appointment of accounting firms, protect shareholder interests, and improve audit quality [1] - The term "selection of accounting firms" refers to the hiring of firms to provide audit opinions and reports on financial statements [1] Group 2: Requirements for Accounting Firms - Selected accounting firms must possess relevant qualifications as per national regulatory authorities and the China Securities Regulatory Commission [2] - Firms should have a stable workplace, sound organizational structure, and effective internal management and control systems [2] - A good record of audit quality and the ability to undertake associated risks are essential [2] - Firms must comply with financial auditing laws and possess registered accountants capable of ensuring audit quality [2] Group 3: Selection Procedures - The selection process requires approval from the audit committee and the board of directors, followed by a decision from the shareholders' meeting [2] - The audit committee is responsible for overseeing the selection process and ensuring compliance with internal controls [2] - Competitive negotiation, public bidding, and other methods must be used to ensure a fair selection process [3] Group 4: Evaluation Standards - The evaluation criteria for accounting firms include audit fees, qualifications, performance records, quality management, and resource allocation [4] - Quality management must account for at least 40% of the evaluation score, while audit fees should not exceed 15% [4] - The company should not set a maximum price unless justified in the selection documents [4] Group 5: Audit Fee Adjustments - Audit fees can be adjusted based on changes in consumer price index, average wage levels, and business complexity [5] - If audit fees decrease by 20% or more compared to the previous year, the company must disclose the reasons and details in its information disclosure documents [5] Group 6: Supervision and Reporting - The audit committee must evaluate the performance of the accounting firm annually and report to the board of directors [6] - Any changes in accounting firms must be disclosed, including reasons and communication with previous firms [6] - The company must maintain records of all selection and evaluation documents for at least 10 years [7] Group 7: Miscellaneous Provisions - In case of inconsistencies with laws or regulations, the relevant legal provisions will prevail [8] - The board of directors is responsible for interpreting the selection system [8] - The system takes effect upon approval by the board of directors [8]

General Overview - Jiangsu Kangzhong Digital Medical Technology Co., Ltd. aims to improve its corporate governance structure by defining the responsibilities of the general manager and regulating the exercise of powers to promote stable and healthy development of the company [1] Qualifications and Appointment Procedures - The general manager must possess rich economic and management knowledge, strong management capabilities, and relevant work experience [2] - The general manager is appointed or dismissed by the board of directors, with a term of three years, and can be reappointed [2][3] Powers of the General Manager - The general manager is responsible for the company's production, management, and implementation of board resolutions, and must report to the board [4] - The general manager has the authority to propose the appointment or dismissal of senior management and to decide on the hiring of other management personnel [4] Responsibilities of the General Manager - The general manager is tasked with implementing the annual operational plans, financial budgets, and employee welfare programs as decided by the board [5] - Responsibilities also include formulating internal management structures, basic regulations, and specific management rules [5] Meeting and Reporting Structure - The general manager convenes meetings with senior management to discuss major operational decisions, ensuring scientific decision-making [6] - Regular reports on company operations and financial statements must be submitted to the board and audit committee [9]

江苏康众数字医疗科技股份有限公司 第三条 公司及其子公司与关联方之间的关联交易应签订书面协议。协议的 签订应当遵循平等、自愿、等价、有偿的原则，协议内容应明确、具体、可执行。 第四条 公司发生关联交易，应当保证关联交易的合法性、必要性、合理性 和公允性，保持公司的独立性，不得利用关联交易调节财务指标，损害公司利益。 第六条 公司的关联人，指具有下列情形之一的自然人、法人或其他组织： 关联交易管理办法 第一章 总则 （一）直接或者间接控制上市公司的自然人、法人或其他组织； （二）直接或间接持有上市公司 5%以上股份的自然人； 第一条 为进一步完善江苏康众数字医疗科技股份有限公司（以下简称"公 司"、"上市公司"或者"本公司"）的关联交易行为，促进公司规范运作和健 康发展，保护投资者合法权益，根据《中华人民共和国公司法》《中华人民共和 国证券法》《上市公司治理准则》《上市公司监管指引第 8 号——上市公司资金往 来、对外担保的监管要求》《上海证券交易所科创板股票上市规则》《上海证券交 易所科创板上市公司自律监管指引第 1 号——规范运作》及《江苏康众数字医疗 科技股份有限公司章程》（以下简称"《公司章程》"）等有 ...